The European Union has announced the purchase of 55,000 doses of the Roche-Regeneron Covid-19 drug, marking its first foray into potential treatments involving a cocktail of monoclonal antibodies.
The EU announced it secured the shipment of the doses on Wednesday, as the bloc seeks to expand its portfolio of drugs and explores potentially promising treatments that can help in the fight against the virus.
Continue reading https://on.rt.com/b9j4